|Company Name||Last Price||%
|Dr Reddys Labs||2676.50||-0.47||2939.80||1786.50||45,529.64|
|Dec' 13||Sep' 13||Jun' 13||Mar' 13|
|No Mutual Funds Holding the share|
Ind-Swift is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 25.40 crore.The company has reported a standalone sales of Rs 105.78 crore and a Net Loss of Rs 37 crore for the quarter ended Dec 2013.
The company management includes S R Mehta - Chairman, N R Munjal - Vice Chairman, Gopal Munjal - Managing Director & CEO, V R Mehta - Joint Managing Director, Himanshu Jain - Director, Rishav Mehta - Director, K M S Nambiar - Director, R S Bedi - Director, H P S Chawla - Director, S K Mathur - Director, S P Sharma - Independent Director, Atul Saxena - Nominee Director.
It is listed on the BSE with a BSE Code of 524652 and the NSE with an NSE Code of INDSWFTLTD.
Its Registered office is at 781, Industrial Area - II , Chandigarh,Chandigarh - 160002.
Their Registrars are Alankit Assignment Ltd.